Core Insights - American Oncology Network (AON) has launched LabVizor, a cloud-based anatomic pathology laboratory information system (LIS) developed by SigmaCore, aimed at enhancing efficiency in pathology and oncology labs [1][2] - LabVizor is designed to meet the unique needs of oncologists and pathologists, integrating complex pathology reports into a streamlined system [2][3] - The platform is fully integrated with AON's electronic medical record (EMR) system, allowing for bidirectional data exchange and improving clinical decision-making [3] Company Overview - AON is one of the fastest-growing community oncology networks in the U.S., representing over 290 providers across 21 states since its founding in 2018 [5][6] - SigmaCore is a pathology practice management consultancy focused on empowering pathologists and optimizing pathology practices [7][8] Product Features - Key features of LabVizor include Pre-Accessioning for workflow planning, Integrated Reporting for seamless diagnostic information presentation, and a User-Friendly Dashboard for comprehensive lab operations monitoring [4][5] - LabVizor also offers Data Analytics for generating data-driven reports and Collaboration Tools for effective workflow management among team members [4][5] Strategic Goals - AON aims to leverage advanced technology like LabVizor to enhance cancer care, improve diagnostic accuracy, and ensure patient-centered services [4][6] - The integration of LabVizor aligns with AON's mission to expand access to high-quality cancer care in local communities [4][6]

Core Insights - Florida Oncology and Hematology (FOH) has welcomed Dr. Michele Ramirez, a board-certified medical oncologist and hematologist, to its physician care team, enhancing its capacity to provide patient-centered cancer care in Naples, Florida [1][4]. Company Overview - Florida Oncology and Hematology specializes in the diagnosis and treatment of cancer and blood disorders, serving patients in multiple locations including Cape Coral, Clearwater, Fort Myers, and Naples, Florida [6]. - The practice is committed to delivering innovative cancer care based on research and evidence-based medicine, offering a comprehensive range of services including diagnosis, treatment, clinical trials, survivorship, and patient support [3][6]. Team Expansion - With the addition of Dr. Ramirez, the FOH team now consists of eight medical oncologists and ten advanced practice providers across five locations in Florida [3]. - Dr. Ramirez brings over 20 years of experience in oncology and hematology, having practiced in Florida since 2002, and is dedicated to providing high-quality, patient-centered care [2][3]. Organizational Commitment - American Oncology Network (AON), the partner organization of FOH, focuses on ensuring the long-term success of community oncology through innovative healthcare solutions and a physician-led model [5]. - AON aims to promote health equity by addressing disparities in cancer care and ensuring all patients have access to necessary treatments for optimal health outcomes [5].

Core Insights - MidAmerica Cancer Care (MACC) has joined the American Oncology Network (AON), enhancing its capabilities in patient-focused services and clinical trials [1][2][4] Company Overview - MACC, established in 2019, provides community-based oncology services in Kansas City and western Missouri, staffed by six Board-certified medical oncologists and 16 advanced practitioners [3][7][8] - The organization focuses on comprehensive cancer care, including diagnostics, treatment, clinical trials, survivorship programs, and patient support, all aimed at reducing travel burdens for patients [3][8] Partnership Details - The collaboration with AON allows MACC to expand its service offerings and improve patient outcomes while maintaining a patient-centered approach [2][3] - AON, founded in 2018, represents over 290 providers across 21 states and aims to enhance community oncology through innovative healthcare solutions and value-based care [5][6] Strategic Goals - The partnership supports AON's mission to expand access to high-quality cancer care in local communities and demonstrates its ability to collaborate with physician groups and hospital systems [4][6] - Both organizations are committed to promoting health equity and addressing disparities in cancer care [6]

Core Insights - Florida Oncology and Hematology has relocated its clinic in Fort Myers to a new state-of-the-art facility to enhance cancer care for the community [1][3] - The new clinic features 12 exam rooms, nearly 30 infusion chairs, an onsite lab, and a specialty pharmacy for oral oncolytics [1][2] - The practice is part of the American Oncology Network, which supports community-based oncology practices and provides additional patient care services [4][6] Company Overview - Florida Oncology and Hematology specializes in the diagnosis and treatment of cancer and blood disorders, serving patients in Cape Coral, Clearwater, Fort Myers, and Naples [8] - The practice emphasizes personalized care and treatment plans tailored to individual patient needs, ensuring high-quality treatment in a comfortable environment [3][8] - American Oncology Network, founded in 2018, is rapidly expanding with over 290 providers across 21 states, focusing on value-based care and improving patient outcomes [6][7] Services and Facilities - The new Fort Myers location includes private exam rooms for patient-physician discussions, an infusion room, in-house lab and pathology services, and an onsite specialty pharmacy [2][5] - The relocation allows for expanded patient services and therapeutics, as well as a larger space for staff to provide one-on-one care [5] - AON provides integrated revenue-diversifying ancillary services and practice management expertise to support independent physicians [7]

Company Announcement - American Oncology Network (AON) appoints Charlie Goddard as General Counsel [1] - Goddard brings over 15 years of legal experience in healthcare law, corporate governance, and compliance, with expertise in fraud and abuse prevention, data privacy, cybersecurity, dispute resolution, and high-stakes commercial transactions [2] - Goddard previously held positions at an AmLaw 100 firm and served as General Counsel for a leading orthopedic surgery group [3] Leadership Perspective - AON's CEO, Todd Schonherz, highlights Goddard's healthcare expertise as a perfect fit for the role, emphasizing his deep knowledge of health law as invaluable for AON's growth [2] - AON's Chief Medical Officer, Stephen "Fred" Divers, MD, notes that Goddard's expertise will help navigate the evolving healthcare landscape and advance strategic initiatives [3] Company Overview - AON is an alliance of physicians and healthcare leaders focused on ensuring the long-term success of community oncology and other specialties [5] - Founded in 2018, AON's network includes over 290 providers across 21 states, pioneering innovative healthcare solutions through a physician-led model [5] - AON promotes health equity by addressing disparities in cancer care and ensuring access to quality care for all patients [5] Mission and Vision - AON's mission is to make cancer care affordable and accessible in communities across the country [3] - The company focuses on value-based care, improving patient outcomes while reducing costs and expanding access to quality care [5] - AON is committed to shaping the future of community oncology through innovation and collaboration [6]

Core Viewpoint - Fort Wayne Medical Oncology and Hematology (FWMOH) has joined the American Oncology Network (AON), enhancing its patient-focused services and maintaining high-quality cancer care in northeastern Indiana [1][4]. Company Overview - FWMOH has been providing cancer care since 1977 and operates nine locations in northeastern Indiana, staffed by 16 Board-certified medical oncologists and two Board-certified gynecologic oncologists [2][6]. - The organization treats over 40 types of cancer and various blood disorders, emphasizing compassionate, patient-centered care [6][7]. Partnership Details - The partnership with AON allows FWMOH to pursue growth initiatives and innovations, enhancing care for more patients in the region [2][3]. - AON, founded in 2018, represents over 290 providers across 21 states and focuses on value-based care, improving patient outcomes while reducing costs [10]. Service Offerings - FWMOH provides comprehensive cancer care, including laboratory services, PET/CT imaging, oral and IV infusion treatment options, clinical trials, and survivorship programs [3][6]. - The facilities are designed for patient comfort, featuring private exam rooms and on-site infusion suites [3]. Leadership Statements - Dr. Praveen Kollipara, president of FWMOH, expressed excitement about the partnership, highlighting recent expansions and the addition of leading gynecologic oncologists [2]. - AON's leadership emphasized the shared commitment to high-quality, patient-centered care and the expertise FWMOH brings to the network [4][5].

Group 1: ASH Annual Meeting - The ASH Annual Meeting is a premier event for hematology research, with over 5,000 scientific abstracts submitted annually, showcasing significant contributions to the field [1] - Selected abstracts undergo rigorous peer review, highlighting vital advancements in cancer care [4] Group 2: American Oncology Network (AON) - AON is an alliance of physicians and healthcare leaders focused on the long-term success of community oncology, founded in 2018, representing over 250 providers across 21 states [4] - AON promotes innovative healthcare solutions through a physician-led model, emphasizing value-based care to improve patient outcomes while reducing costs [4] - The organization is committed to health equity, addressing disparities in cancer care to ensure all patients have access to necessary care [4] Group 3: Hematology Oncology of Indiana - Hematology Oncology of Indiana is a community-based practice providing treatment for various cancers and blood disorders, focusing on compassionate patient-centered care [5] - Physicians from Hematology Oncology of Indiana presented impactful research findings at the 66th ASH Annual Meeting, emphasizing their commitment to advancing cancer care [6][9] - The practice co-authored a study on CAR T-Cell Therapy integration in community oncology centers, published in the November supplemental issue of Blood [7]

Core Viewpoint - American Oncology Network (AON) has achieved reaccreditation from the Accreditation Commission for Health Care (ACHC), highlighting its commitment to high-quality patient care and compliance with national standards [1][5]. Company Overview - AON is one of the fastest-growing oncology networks in the United States, founded in 2018, and represents over 250 providers across 21 states [1][5]. - The organization focuses on innovative healthcare solutions through a physician-led model, promoting value-based care that enhances patient outcomes while reducing costs [5]. - AON aims to address disparities in cancer care and ensure equitable access to healthcare for all patients [5]. Specialty Pharmacy Operations - AON's specialty pharmacy collaborates with physicians and pharmacists to deliver oral cancer medications directly to patients' homes, ensuring quick dispensing and shipping [4]. - The pharmacy team also assists patients with insurance claims and connects them to financial assistance programs [4]. Accreditation Significance - ACHC accreditation signifies an organization's dedication to meeting rigorous standards for performance and patient care [2][3]. - ACHC has been a recognized symbol of quality since 1986 and is ISO 9001:2015 certified, with authority from the Centers for Medicare & Medicaid Services (CMS) [3][6].

FORT MYERS, FL, Dec. 19, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (OTCQX:AONC), one of the fastest-growing oncology networks in the United States, proudly announces that its specialty pharmacy has achieved reaccreditation from the Accreditation Commission for Health Care (ACHC). Accreditation is a process through which health care organizations demonstrate compliance with national standards. ACHC accreditation reflects an organization's dedication to meeting standards that facilitate a highe ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-04177 American Oncology Network, Inc. (Exact name of registrant as specified in its charter) Delaware 85-3984427 (State or other jurisdiction of incorp ...